EORTC presentations at CTOS
7 Nov 2016
EORTC will present four abstracts at the Connective Tissue Oncology Society (CTOS) 21st Annual Meeting, which will take place from 9 to 12 Novembre 2016 in Lisbon, Portugal.
Oral abstract session
Second Safety Analysis of A Phase III Randomized Study of Pre-Operative Radiotherapy (RT) Plus Surgery Versus Surgery Alone for Patients With Retro Peritoneal Sarcoma (RPS) – EORTC 62092-22092- STRASS
Oral Session STS: Retroperitoneal STS; Thu 10.11.2016 – 5:10 PM to 5:55 PM
Authors: Sylvie Bonvalot, Rick L. M. Haas, Saskia Litière, Cecile Le Pechoux, Dirk C Strauss, Carol Jane Swallow, Piotr Rutkowski, Chandrajit P. Raut, Michela Lia, Sandrine Marréaud, Alessandro Gronchi
Poster sessions
Prognosis of Patients Receiving First Line Chemotherapy for Advanced Soft Tissue Sarcomas with Locally Advanced Vs Distant Metastasis Vs Both: An EORTC-STBSG Database Analysis
Poster Session 2: STS 095; Friday 11.11.2016 – 6:15 PM to 7:00 PM
Authors: A.J. Verschoor, S. Litière, S. Marréaud, I. Judson, M. Toulmonde, E. Wardelmann, W. van der Graaf, A. Le Cesne, A. Gronchi, H. Gelderblom
Prospective Validation Of A Molecular Signature Predictive Of Response To Trabectedin In Soft-Tissue Sarcomas Within EORTC 62091 Trial
Poster Session 2: STS 096; Friday 11.11.2016 – 6:15 PM to 7:00 PM
Authors: Italiano A, Touati N, Litière S, Butrynski JE, Penel N, Blay JY, Isambert N, Milhem M, Kerst JM, Reyners AKL, Marréaud S, Collin F, Van der Graaf WT, Gelderblom AJ, Gronchi A
Impact on outcome of concomitant administration of gastric acid suppression (GAS) therapy and pazopanib in soft tissue sarcoma (STS) patients treated within EORTC 62043/62072 trials.
Poster Session 2: STS 113; Friday 11.11.2016 — 6:15 PM to 7:00 PM
Authors: Mir O, Touati N, Lia M, Litière S, Le Cesne A, Sleijfer S, Leahy M, Young R, Mathijssen R, Van Erp NP, Gelderblom AJ, Van der Graaf WT, Gronchi A
Pazopanib In Advanced Vascular Sarcomas: An EORTC Soft Tissue And Bone Sarcoma Group Retrospective Analysis
Poster Session 2: STS 123; Friday 11.11.2016 — 6:15 PM to 7:00 PM
Authors: Kollár A, Jones RL, Stacchiotti S, Gelderblom H, Guida M, Boccone P, Steeghs N, Safwat A, Katz D, Duffaud F, Sleijfer S, van der Graaf WT, Touati N, Litière S, Marréaud S, Gronchi A, Kasper B
Related News
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026
